GeneFinder COVID-19 Plus RealAmp Kit

ITALY, Torino, Feb, 26, 2020. ELITechGroup is pleased to announce the release of the kit GeneFinderTM COVID-19 Plus RealAmp Kit, the Kit is CE – IVD and permits to detect Sars-CoV-2 as well known as Coronavirus, Real-time PCR assay on a Sample to Result Platform: ELITe InGenius® The kit detects three genes RdRP gene, E gene and N gene and is fully compliance on the reccomended protocol WHO. Moreover the kit has the Endogenous Internal Control The kit has been developed in collaboration with OSANGHealthcare, to demonstrate a strong committment from ELITechGroup Molecular Diagnostic to be in first Line against this Epidemic Virus Download Here Teaser CoronaVirus About ELITechGroup: ELITechGroup is a privately held group of worldwide manufacturers and distributors of in vitro diagnostic equipment and reagents. By bringing together IVD specialty companies that offer innovative products and solutions, ELITechGroup has become a major contributor in advancing clinical diagnostics to laboratories in the proximity market, those operating closer to the patient.    “

Latest news


ELIVERSE: the video teaser   ElitechGroup Mdx is pleased to announce that ELIVERSE will be launched in Europe in 2024. With its introduction, ELITechGroup will have launched three molecular sample-to-result platforms in 8 years. Read the press release here.

ELITechGroup Clinical Chemistry Introduces eLITROL SelectQC™

ELITechGroup Clinical Chemistry Introduces eLITROL SelectQC™ – A Comprehensive Web-Based IQC Platform for Selectra System Users ELITechGroup Clinical Chemistry is proud to announce the launch of eLITROL SelectQC™, a new web-based internal quality control (IQC) platform designed for all Selectra System users in clinical chemistry laboratories. The platform offers comprehensive…

Let us help you

For general inquiries, please use the links to the right. The Contact link leads to a brief online form, and the Support link offers general phone and email information. Someone will be in touch with you soon.